[Treatment of multiple sclerosis: current opinion].
Yamamura
T
T
Department of Immunology, National Institute of Neuroscience, NCNP, 4-1-1 Ogawahigashi, Kodaira, Tokyo 187-8502, Japan.
D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D007371:Interferon-gamma / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000276:immunology / Q000628:therapy*; D013601:T-Lymphocytes / Q000276:immunology; D018417:Th1 Cells / Q000502:physiology; D018418:Th2 Cells / Q000502:physiology
D016756:Immunoglobulins, Intravenous; D007371:Interferon-gamma